Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)

Published:2018-04 Issue: Volume:52 Page:171-179
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Bergquist John R.^ORCID,Shah Harsh N.,Habermann Elizabeth B.^ORCID,Hernandez Matthew C.^ORCID,Ivanics Tommy,Kendrick Michael L.,Smoot Rory L.,Nagorney David M.,Borad Mitesh J.,McWilliams Robert R.,Truty Mark J.

Funder

Center for the Science of Health Care Delivery

Mayo Clinic Clinician Investigator Training program

Clinician Investigator Training Program

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference32 articles.

1. Gallbladder cancer;Misra;Curr. Treat. Options Gastroenterol.,2006

2. Carcinoma of the gallbladder;Misra;Lancet Oncol.,2003

3. Gallbladder cancer worldwide: Geographical distribution and risk factors;Randi;Int. J. Canc.,2006

4. Gallbladder cancer — a comprehensive review;Lai;Surgery (St Louis),2008

5. A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada;Ghadirian;Rev. Epidemiol. Sante Publique,1993

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Therapy Use for Patients With Inadequately Resected T1b-T3 Gallbladder Cancer;Journal of Surgical Research;2024-10

2. Simple versus radical cholecystectomy and survival for pathologic stage T1B gallbladder cancer;HPB;2024-04

3. Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis;European Journal of Surgical Oncology;2024-04

4. New trends in diagnosis and management of gallbladder carcinoma;World Journal of Gastrointestinal Oncology;2024-01-15

5. Physician decision-making in the use of adjuvant chemotherapy for lymph node-positive gallbladder cancer;HPB;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3